Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes

Cited by (1,000)

Items 101–200 of 1,000

1. Comparing Effectiveness and Safety of SGLT2 Inhibitors vs DPP-4 Inhibitors in Patients With Type 2 Diabetes and Varying Baseline HbA 1c Levels
   Elvira D’Andrea, Deborah J. Wexler, Seoyoung C. Kim, Julie M. Paik, Ethan M. Alt, Elisabetta Patorno · 2023 · JAMA Internal Medicine
2. Sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists and the risk for cardiovascular outcomes in routine care patients with diabetes across categories of cardiovascular disease
   Patorno, Elisabetta, Htoo, Phyo T., Glynn, Robert J., Schneeweiss, Sebastian, Wexler, Deborah J., Pawar, Ajinkya, Bessette, Lily G., Chin, Kristyn, Everett, Brendan M., Kim, Seoyoung C. · 2021 · Annals of Internal Medicine
3. Personalized management of dyslipidemias in patients with diabetes—it is time for a new approach (2022)
   Maciej Banach, Stanisław Surma, Željko Reiner, Niki Katsiki, Peter Edward Penson, Zlatko Fras, Amirhossein Sahebkar, Francesco Paneni, Manfredi Rizzo, John J.P. Kastelein · 2022 · Cardiovascular Diabetology
4. Mitophagy in Diabetic Cardiomyopathy: Roles and Mechanisms
   Haoxiao Zheng, Hailan Zhu, Xinyue Liu, Xiaohui Huang, Anqing Huang, Yuli Huang · 2021 · Frontiers in Cell and Developmental Biology
5. Beverage consumption and mortality among adults with type 2 diabetes: prospective cohort study
   Le Ma, Yang Hu, Derrick Johnston Alperet, Gang Liu, Vasanti Malik, JoAnn Elisabeth Manson, Eric B. Rimm, Frank B. Hu, Qi Sun · 2023 · BMJ
6. Cardiovascular Disease and Risk Management: Review of the American Diabetes Association Standards of Medical Care in Diabetes 2018
   James J. Chamberlain, Eric L. Johnson, Sandra Leal, Andrew S. Rhinehart, Jay H. Shubrook, Lacie Peterson · 2018 · Annals of Internal Medicine
7. Macrovascular disease and risk factors in youth with type 1 diabetes: time to be more attentive to treatment?
   Petter Bjornstad, Kim C. Donaghue, David M. Maahs · 2018 · The Lancet Diabetes & Endocrinology
8. The discovery of insulin revisited: lessons for the modern era
   Gary F. Lewis, Patricia Lee Brubaker · 2021 · Journal of Clinical Investigation
9. Obstructive Sleep Apnea, a Risk Factor for Cardiovascular and Microvascular Disease in Patients With Type 2 Diabetes: Findings From a Population-Based Cohort Study
   Nicola Jaime Adderley, Anuradhaa Subramanian, Konstantinos A. Toulis, Krishna Margadhamane Gokhale, Thomas Taverner, Wasim Hanif, Shamil MM Haroon, G. Neil Thomas, Christopher A. R. Sainsbury, Abd A. Tahrani et al. · 2020 · Diabetes Care
10. Reduced Long‐Term Risk of Aortic Aneurysm and Aortic Dissection Among Individuals With Type 2 Diabetes Mellitus: A Nationwide Observational Study
    Tarik Avdic, Stefan Franzén, Moncef Zarrouk, Stefan Acosta, Peter M. Nilsson, Anders Gottsäter, Ann‐Marie Svensson, Soffia Guðbjörnsdóttir, Björn Eliasson · 2018 · Journal of the American Heart Association
11. The pathogenic role of coronary microvascular dysfunction in the setting of other cardiac or systemic conditions
    Regina E. Konst, Tomasz Jan Guzik, Juan Carlos Kaski, Angela H.E.M. Maas, Suzette E. Elias‐Smale · 2020 · Cardiovascular Research
12. Twenty-Five Years of Evolution and Hurdles in Electronic Health Records and Interoperability in Medical Research: Comprehensive Review
    Yun Shen, Jiamin Yu, Jian Zhou, Gang Hu · 2024 · Journal of Medical Internet Research
13. Postprandial glucose spikes, an important contributor to cardiovascular disease in diabetes?
    Hanssen, Nordin M. J., Kraakman, Michael J., Flynn, Michelle C., Nagareddy, Prabhakara R., Schalkwijk, Casper G., Murphy, Andrew J. · 2020 · Frontiers in Cardiovascular Medicine
14. Exploring the role of extracellular matrix proteins to develop biomarkers of plaque vulnerability and outcome
    Signe Holm Nielsen, Lena Jonasson, Konstantinos Kalogeropoulos, M.A. Karsdal, Alexander Lynge Reese‐Petersen, Ulrich auf dem Keller, Federica Genovese, Jan Åke Nilsson, Isabel Gonçalves · 2020 · Journal of Internal Medicine
15. Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes Mellitus
    Marian Sue Kirkman, Hussain Mahmud, Mary T. Korytkowski · 2018 · Endocrinology and Metabolism Clinics of North America
16. Systematic Review of Polygenic Risk Scores for Type 1 and Type 2 Diabetes
    Felipe Padilla-Martínez, Francois Collin, Mirosław Kwaśniewski, Adam Jacek Kretowski · 2020 · International Journal of Molecular Sciences
17. Mediators of the association between educational attainment and type 2 diabetes mellitus: a two-step multivariable Mendelian randomisation study
    Jia Zhang, Zekai Chen, Katri Pärna, Sander K. R. van Zon, Harold Snieder, Chris H. L. Thio · 2022 · Diabetologia
18. Periconception glycaemic control in women with type 1 diabetes and risk of major birth defects: population based cohort study in Sweden
    Jonas Filip Ludvigsson, Martin Neovius, Jonas K. Söderling, Soffia Guðbjörnsdóttir, Ann‐Marie Svensson, Stefan Franzén, Olof Stephansson, Björn Pasternak · 2018 · BMJ
19. Microvascular complications burden (nephropathy, retinopathy and peripheral polyneuropathy) affects risk of major vascular events and all-cause mortality in type 1 diabetes: a 10-year follow-up study
    Monia Garofolo, Elisa Gualdani, ROSA GIANNARELLI, Michele Aragona, Fabrizio Campi, Daniela Lucchesi, Giuseppe Daniele, Roberto Miccoli, Paolo Francesconi, Stefano Del Prato et al. · 2019 · Cardiovascular Diabetology
20. Negative pressure wound therapy use in diabetic foot syndrome—from mechanisms of action to clinical practice
    Sebastian Borys, Jerzy Hohendorff, Claudia Frankfurter, Beata Kieć‐Wilk, Maciej Tadeusz Malecki · 2019 · European Journal of Clinical Investigation
21. Cardiovascular disease prevalence and risk factor prevalence in Type 2 diabetes: a contemporary analysis
    Stuart J. McGurnaghan, Luke A. K. Blackbourn, Emina Mocevic, Ulrik Haagen Panton, Rory J. McCrimmon, Naveed A. Sattar, Sarah H. Wild, Helen Martina Colhoun · 2018 · Diabetic Medicine
22. Lipoprotein (a) predicts recurrent worse outcomes in type 2 diabetes mellitus patients with prior cardiovascular events: a prospective, observational cohort study
    Yan Zhang, Jing‐Lu Jin, Ye‐Xuan Cao, Huiwen Zhang, Yuan‐Lin Guo, Na‐Qiong Wu, Cheng‐Gang Zhu, Ying Gao, Qi Hua, Yanfang Li et al. · 2020 · Cardiovascular Diabetology
23. Prediction of type 2 diabetes using genome-wide polygenic risk score and metabolic profiles: A machine learning analysis of population-based 10-year prospective cohort study
    Seok-Ju Hahn, Suhyeon Kim, Young Sik Choi, Junghye Lee, Jihun Kang · 2022 · EBioMedicine
24. A systematic review investigating the identification, causes, and outcomes of delays in the management of chronic limb-threatening ischemia and diabetic foot ulceration
    Andrew Nickinson, Bernadeta M Bridgwood, John S M Houghton, Sarah Nduwayo, Coral Pepper, Tanya J. Payne, Matthew J. Bown, Robert Davies, Rob D. Sayers · 2019 · Journal of Vascular Surgery
25. Long-term population-based trends in the incidence of cardiovascular disease in individuals with type 1 diabetes from Finland: a retrospective, nationwide, cohort study
    Harjutsalo, Valma, Pongrac Barlovic, Drazenka, Groop, Per-Henrik · 2021 · The Lancet Diabetes & Endocrinology
26. Trends in the Prevalence of Diabetes Among U.S. Adults: 1999–2016
    Fang, Michael · 2018 · American Journal of Preventive Medicine
27. Predicting and preventing heart failure in type 2 diabetes
    Ambarish Pandey, Muhammad Shahzeb Khan, Kershaw V. Patel, Deepak L. Bhatt, Subodh Verma · 2023 · The Lancet Diabetes & Endocrinology
28. Metabolic, structural and biochemical changes in diabetes and the development of heart failure
    Kim L. Ho, Qutuba G. Karwi, David Connolly, Simran Pherwani, Ezra B. Ketema, John R. Ussher, Gary D. Lopaschuk · 2022 · Diabetologia
29. Does type 2 diabetes confer higher relative rates of cardiovascular events in women compared with men?
    Morten Winther Malmborg, Michelle Schmiegelow, Caroline Holm Nørgaard, Anders Munch, Thomas Alexander Gerds, Morten Schou, Caroline Kistorp, Christian Tobias Torp-Pedersen, Mark Andrew Hlatky, Gunnar Gislason · 2019 · European Heart Journal
30. HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target
    Antonio Ceriello, Giuseppe Lucisano, Francesco Prattichizzo, Rosalba La Grotta, Stefan Franzén, Ann‐Marie Svensson, Björn Eliasson, Antonio Nicolucci · 2022 · Cardiovascular Diabetology
31. Impact of type 2 diabetes mellitus on short- and long-term mortality after coronary artery bypass surgery
    Alexander Kogan, Eilon Ram, Shany Levin, Enrique Z. Fisman, Alexander Tenenbaum, Ehud Raanani, Leonid Sternik · 2018 · Cardiovascular Diabetology
32. Monocytes and macrophages as protagonists in vascular complications of diabetes
    Kanter, Jenny E., Hsu, Cheng-Chieh, Bornfeldt, Karin E. · 2020 · Frontiers in Cardiovascular Medicine
33. Screening for glucose perturbations and risk factor management in dysglycemic patients with coronary artery disease—a persistent challenge in need of substantial improvement: a report from ESC EORP EUROASPIRE V
    Ferrannini, Giulia, De Bacquer, Dirk, De Backer, Guy, Kotseva, Kornelia, Mellbin, Linda, Wood, David, Rydén, Lars, EUROASPIRE V collaborators, Gale, Christopher P., Beleslin, Branko et al. · 2020 · Diabetes Care
34. Coronary No-Reflow after Primary Percutaneous Coronary Intervention—Current Knowledge on Pathophysiology, Diagnosis, Clinical Impact and Therapy
    Gjin Ndrepepa, Adnan Kastrati · 2023 · Journal of Clinical Medicine
35. A systematic review of trends in all-cause mortality among people with diabetes
    Lei Chen, Rakibul M. Islam, Joanna Nan Wang, Thomas R. Hird, Meda E. Pavkov, Edward W. Gregg, Agus Salim, Maryam Tabesh, Digsu N. Koye, Jessica L. Harding et al. · 2020 · Diabetologia
36. Effect of Steviol Glycosides on Human Health with Emphasis on Type 2 Diabetic Biomarkers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Camilla Christine Bundgaard Anker, Shamaila Rafiq, Per Bendix Jeppesen · 2019 · Nutrients
37. Composite Primary End Points in Cardiovascular Outcomes Trials Involving Type 2 Diabetes Patients: Should Unstable Angina Be Included in the Primary End Point?
    Nikolaus Marx, Darren K. McGuire, Vlado Perkovic, Hans‐Juergen Woerle, Uli C. Broedl, Maximilian von Eynatten, Jyothis Thomas George, Julio Rosenstock · 2017 · Diabetes Care
38. Pump, pipes, and filter: do SGLT2 inhibitors cover it all?
    Subodh Verma, Peter Jüni, C. David Mazer · 2018 · The Lancet
39. Lipid-lowering in diabetes: An update
    Alan Chait, Robert H. Eckel, Michal Vrablı́k, Alberto Zambon · 2023 · Atherosclerosis
40. Risk of atrial fibrillation in people with type 1 diabetes compared with matched controls from the general population: a prospective case-control study
    Dahlqvist, Sofia, Rosengren, Annika, Gudbjörnsdottir, Soffia, Pivodic, Aldina, Wedel, Hans, Kosiborod, Mikhail, Svensson, Ann-Marie, Lind, Marcus · 2017 · The Lancet Diabetes & Endocrinology
41. Trends in the Incidence of Hospitalization for Major Diabetes-Related Complications in People With Type 1 and Type 2 Diabetes in Australia, 2010–2019
    Jedidiah I Morton, Peter Anthony Lazzarini, Jonathan E. Shaw, Dianna J. Magliano · 2022 · Diabetes Care
42. Research progress of active ingredients of Scutellaria baicalensis in the treatment of type 2 diabetes and its complications
    Wang Yingrui, Liu Zheng, Liu Guoyan, Wang Hong-jie · 2022 · Biomedicine & Pharmacotherapy
43. NT‐proBNP by Itself Predicts Death and Cardiovascular Events in High‐Risk Patients With Type 2 Diabetes Mellitus
    Marcus Vinícius Bolívar Malachias, Pardeep S. Jhund, Brian Lee Claggett, Magnus Olof Wijkman, Rhonda Bentley–Lewis, Nish Chaturvedi, Akshay Suvas Desai, Steven M. Haffner, Hans‐Henrik Parving, MARGARET FORNEY PRESCOTT et al. · 2020 · Journal of the American Heart Association
44. Association of Baseline and Longitudinal Changes in Body Composition Measures With Risk of Heart Failure and Myocardial Infarction in Type 2 Diabetes: Findings From the Look AHEAD Trial
    Patel, Kershaw V., Bahnson, Judy L., Gaussoin, Sarah A., Johnson, Karen C., Pi-Sunyer, Xavier, White, Ursula, Olson, KayLoni L., Bertoni, Alain G., Kitzman, Dalane W., Berry, Jarett D. et al. · 2020 · Circulation
45. Glucose-lowering therapies in patients with type 2 diabetes and cardiovascular diseases
    Francesco Prattichizzo, Lucia La Sala, Lars Rydén, Nikolaus Marx, Marc Ferrini, Paul Elie Valensi, Antonio Ceriello · 2019 · European Journal of Preventive Cardiology
46. Associations between grip strength and incident type 2 diabetes: findings from the UK Biobank prospective cohort study
    Jirapitcha Boonpor, Solange Liliana Parra-Soto, Fanny Emily Petermann-Rocha, Gérson Ferrari, Paul I. Welsh, Jill P. Pell, Naveed A. Sattar, Jason Martin Regnald Gill, Frederick Ka Wing Ho, Stuart Robert Gray et al. · 2021 · BMJ Open Diabetes Research & Care
47. Schisandrin B Attenuates Diabetic Cardiomyopathy by Targeting MyD88 and Inhibiting MyD88‐Dependent Inflammation
    Wu Luo, Ke Lin, Junyi Hua, Jibo Han, Qiuyan Zhang, Lingfeng Chen, Zia Ali Khan, Gaojun Wu, Yi Wang, Guang Liang · 2022 · Advanced Science
48. Risk of cancer incidence and mortality associated with diabetes: A systematic review with trend analysis of 203 cohorts
    Suping Ling, Karen Brown, Joanne K. Miksza, Lynne M. Howells, Amy Morrison, Eyad Issa, Thomas E. Yates, Kamlesh Khunti, Melanie Jane Davies, Francesco Zaccardi · 2020 · Nutrition Metabolism and Cardiovascular Diseases
49. Carbohydrate restriction for diabetes: rediscovering centuries-old wisdom
    Belinda S Lennerz, Andrew Paul Koutnik, Svetlana Azova, Joseph I. Wolfsdorf, David S. Ludwig · 2021 · Journal of Clinical Investigation
50. Mortality trends in type 1 diabetes: a multicountry analysis of six population-based cohorts
    Ruiz, Paz L. D., Chen, Lei, Morton, Jedidiah I., Salim, Agus, Carstensen, Bendix, Gregg, Edward W., Pavkov, Meda E., Mata-Cases, Manel, Mauricio, Didac, Nichols, Gregory A. et al. · 2022 · Diabetologia
51. Cardiovascular disease in type 1 diabetes, an underestimated danger: Epidemiological and pathophysiological data
    Bruno L Vergès · 2023 · Atherosclerosis
52. Glucose variability: a new risk factor for cardiovascular disease
    Martina Belli, Alfonso Bellia, Domenico Sergi, Lucy Barone, Davide Lauro, Francesco Barillà · 2023 · Acta Diabetologica
53. 10-Year Cardiovascular Risk in Patients With Newly Diagnosed Type 2 Diabetes Mellitus
    Christine Gyldenkerne, Martin Bødtker Mortensen, Johnny A. Kahlert, Pernille Gro Thrane, Kevin Kris Warnakula Olesen, Henrik Toft Sørensen, Reimar Wernich Thomsen, Michael Mæng · 2023 · Journal of the American College of Cardiology
54. Predicting coronary heart disease in Chinese diabetics using machine learning
    Cai-Yi Ma, Yamei Luo, Tianyu Zhang, Yu-Duo Hao, Xueqin Xie, Xiaowei Liu, Xiaolei Ren, Xiao-Lin He, Yumei Han, Kejun Deng et al. · 2024 · Computers in Biology and Medicine
55. Role of the adaptive immune system in diabetic kidney disease
    Lingyun Kong, Sofianos Andrikopoulos, Richard J. MacIsaac, Laura K. Mackay, David J. Nikolic‐Paterson, Niloufar Torkamani, Neda Zafari, Evelyn Cristina Santana Marin, Elif Ilhan Ekinci · 2021 · Journal of Diabetes Investigation
56. The Contribution of Cardiac Fatty Acid Oxidation to Diabetic Cardiomyopathy Severity
    Qutuba G. Karwi, Qiuyu Sun, Gary D. Lopaschuk · 2021 · Cells
57. Decreasing incidence of pharmacologically and non-pharmacologically treated type 2 diabetes in Norway: a nationwide study
    Paz Lopez‐Doriga Ruiz, Lars C. Stene, Inger Johanne Bakken, Siri E. Håberg, Kåre I. Birkeland, Hanne Løvdal Gulseth · 2018 · Diabetologia
58. Bone health in type 1 diabetes
    Viral N. Shah, Robert Dana Carpenter, Virginia L. Ferguson, Ann V. Schwartz · 2018 · Current Opinion in Endocrinology Diabetes and Obesity
59. Ag@Au core/shell triangular nanoplates with dual enzyme-like properties for the colorimetric sensing of glucose
    Ao Liu, Mengmeng Li, Jingxiang Wang, Fan Feng, Yu Zhang, Zhiwei Qiu, Yuzhu Chen, Benjamin Edem Meteku, Cong‐Ying Wen, Zifeng Yan et al. · 2019 · Chinese Chemical Letters
60. Diabetes mellitus duration and mortality in patients hospitalized with acute myocardial infarction
    Marta Baviera, Stefano Genovese, Pierluca Colacioppo, Nicola Cosentino, Andreana Foresta, Mauro Tettamanti, Ida Fortino, Maria Carla Roncaglioni, Giancarlo Marenzi · 2022 · Cardiovascular Diabetology
61. Undertreatment of cardiovascular risk factors in the type 1 diabetes exchange clinic network ( United States ) and the prospective diabetes follow‐up (Germany/Austria) registries
    Viral N. Shah, Julia M. Grimsmann, Nicole C. Foster, Axel Dost, Kellee M. Miller, Marianne Pavel, Ruth S. Weinstock, Wölfram Karges, David M. Maahs, Reinhard Walter Holl · 2020 · Diabetes Obesity and Metabolism
62. Validation of a type 1 diabetes algorithm using electronic medical records and administrative healthcare data to study the population incidence and prevalence of type 1 diabetes in Ontario, Canada
    Weisman, Alanna, Tu, Karen, Young, Jacqueline, Kumar, Matthew, Austin, Peter C, Jaakkimainen, Liisa, Lipscombe, Lorraine, Aronson, Ronnie, Booth, Gillian L · 2020 · BMJ Open Diabetes Research & Care
63. Trends in Cardiovascular Complications and Mortality among Patients with Diabetes in South Korea
    Jung Hwan Park, Kyoung Hwa Ha, Bo‐Yeon Kim, Jae Hyuk Lee, Dae Jung Kim · 2020 · Diabetes & Metabolism Journal
64. Presence and Determinants of Cardiovascular Disease and Mortality in Individuals With Type 1 Diabetes of Long Duration: The FinnDiane 50 Years of Diabetes Study
    Valma Harjutsalo, Draženka Pongrac Barlovič, Daniel Gordin, Carol M. Forsblom, George Liang King, Per‐Henrik Groop, the FinnDiane Study Group · 2021 · Diabetes Care
65. Precision prognostics for cardiovascular disease in Type 2 diabetes: a systematic review and meta-analysis
    Abrar Ahmad, Lee‐Ling Lim, Mario Luca Morieri, Claudia H.T. Tam, Feifei Cheng, Tinashe Chikowore, Monika Dudenhöffer‐Pfeifer, Hugo Fitipaldi, Chuiguo Huang, Sarah Kanbour et al. · 2024 · Communications Medicine
66. Novel strategies for glycaemic control and preventing diabetic complications applying the clustering-based classification of adult-onset diabetes mellitus: A perspective
    Hayato Tanabe, Hiroaki Masuzaki, Michio Shimabukuro · 2021 · Diabetes Research and Clinical Practice
67. Ceramides are fuel gauges on the drive to cardiometabolic disease
    Joseph L. Wilkerson, Sean M. Tatum, William L. Holland, Scott A. Summers · 2024 · Physiological Reviews
68. Insulin resistance is associated with preclinical carotid atherosclerosis in patients with type 1 diabetes
    Adriana Pané, Ignacio Conget, Laura Boswell, Sabina Ruiz, Clara Viñals, Verónica Perea, Marga Giménez, Montserrat Cofán, Jesús Blanco, Irene Vinagre et al. · 2020 · Diabetes/Metabolism Research and Reviews
69. Associations of Cardiometabolic Multimorbidity With All-Cause and Coronary Heart Disease Mortality Among Black Adults in the Jackson Heart Study
    Joshua J. Joseph, Aakash Rajwani, Daniel Roper, Songzhu Zhao, David Kline, James B. Odei, Guy Nathaniel Brock, Justin Basile Echouffo-Tcheugui, Rita Rastogi Kalyani, Alain Gerald Bertoni et al. · 2022 · JAMA Network Open
70. Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes: Findings from Prospective Real-life T1D Exchange Registry
    Viral N. Shah, Ryan J. Bailey, Mengdi Wu, Nicole C. Foster, Rodica Pop‐Busui, Michelle L. Katz, Jill P. Crandall, Fida F Bacha, Kristen J. Nadeau, Ingrid M. Libman et al. · 2020 · The Journal of Clinical Endocrinology & Metabolism
71. Impact of diabetes mellitus on mortality rates and outcomes in myocardial infarction
    Volker H. Schmitt, Lukas Hobohm, Thomas F. Münzel, Philip Wenzel, Tommaso Gori, Karsten Keller · 2020 · Diabetes & Metabolism
72. Development and validation of a cardiovascular risk prediction model in type 1 diabetes
    McGurnaghan, Stuart J., McKeigue, Paul M., Read, Stephanie H., Franzen, Stefan, Svensson, Ann-Marie, Colombo, Marco, Livingstone, Shona, Farran, Bassam, Caparrotta, Thomas M., Blackbourn, Luke A. K. et al. · 2021 · Diabetologia
73. Cardiovascular protection in type 2 diabetes: Insights from recent outcome trials
    Clifford J. Bailey, Nikolaus Marx · 2018 · Diabetes Obesity and Metabolism
74. Glucose-lowering therapy and cardiovascular outcomes in patients with type 2 diabetes mellitus and acute coronary syndrome
    Angelo Avogaro, Enzo Bonora, Agostino Consoli, Stefano Del Prato, Stefano Genovese, Francesco Giorgino · 2019 · Diabetes and Vascular Disease Research
75. Chitosan for biomedical applications, promising antidiabetic drug delivery system, and new diabetes mellitus treatment based on stem cell
    Sarah I. Othman, Asma M. Alturki, Gasem Mohammad Abu-Taweel, Naif Ghazi Altoom, Ahmed A. Allam, Rehab Abdelmonem · 2021 · International Journal of Biological Macromolecules
76. Effectiveness of Coenzyme Q10 Supplementation for Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
    Zhang, Shi-ying, Yang, Kai-lin, Zeng, Liu-ting, Wu, Xiao-he, Huang, Hui-yong · 2018 · International Journal of Endocrinology
77. Oxidative stress signaling in the pathogenesis of diabetic cardiomyopathy and the potential therapeutic role of antioxidant naringenin
    Nan Xu, Siqi Liu, Yongqiang Zhang, Yujing Chen, Yumei Zuo, Xiaoqiu Tan, Bin Liao, Pengyun Li, Jian Feng · 2023 · Redox Report
78. Assessing the impact of type 2 diabetes on mortality and life expectancy according to the number of risk factor targets achieved: an observational study
    Bin Wang, Yanqi Fu, Xiao Wei Tan, Ningjian Wang, Lu Qi, Yingli Lu · 2024 · BMC Medicine
79. Hyperglycemia modulates redox, inflammatory and vasoactive markers through specific signaling pathways in cerebral endothelial cells: Insights on insulin protective action
    Angélique Arcambal, Janice Taïlé, Philippe Rondeau, Wildriss Viranaïcken, Olivier Meilhac, Marie‐Paule Gonthier · 2018 · Free Radical Biology and Medicine
80. Plasma metals and cardiovascular disease in patients with type 2 diabetes
    Tengfei Long, Ruixin Wang, Jing Wang, Fei Wang, Yali Xu, Yue Wei, Lue Zhou, Xiaomin Zhang, Jing Yuan, Ping Yao et al. · 2019 · Environment International
81. Sodium-Glucose Cotransporter-2 inhibitors are potential therapeutic agents for treatment of non-diabetic heart failure patients
    Yasuaki Nakagawa, Koichiro Kuwahara · 2020 · Journal of Cardiology
82. Risk stratification and screening for coronary artery disease in asymptomatic patients with diabetes mellitus: Position paper of the French Society of Cardiology and the French-speaking Society of Diabetology
    Paul Elie Valensi, Patrick Henry, Franck Boccara, Emmanuel Cosson, Gaëtan Prévost, Joseph Emmerich, Laura Ernande, Dany Michel Marcadet, Élie Mousseaux, François Rouzet et al. · 2020 · Diabetes & Metabolism
83. Transforming the cardiometabolic disease landscape: multimodal AI-powered approaches in prevention and management
    Muse, Evan D., Topol, Eric J. · 2024 · Cell Metabolism
84. A disease-specific questionnaire for measuring patient-reported outcomes and experiences in the Swedish National Diabetes Register: Development and evaluation of content validity, face validity, and test-retest reliability
    Maria Svedbo Engström, Janeth K. Leksell, Unn‐Britt Johansson, Katarina Eeg‐Olofsson, Sixten Borg, Bo Palaszewski, Soffia Guðbjörnsdóttir · 2017 · Patient Education and Counseling
85. Serum miR-122 levels correlate with diabetic retinopathy
    Nina Pastukh, Ari Meerson, Dorina Kalish, Hanin Jabaly, Arnon Blum · 2019 · Clinical and Experimental Medicine
86. NT-proBNP as a predictor of death and cardiovascular events in patients with type 2 diabetes
    Marcus Vinícius Bolívar Malachias, Magnus Olof Wijkman, Marcello Casaccia Bertoluci · 2022 · Diabetology & Metabolic Syndrome
87. Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines
    Oksana M. Drapkina, Концевая Анна Васильевна, А. М. Калинина, Sergey Nikolaevich Avdeev, Агальцов Михаил Викторович, Л. И. Алексеева, I. I. Almazova, Е. Yu. Andreenko, D. N. Antipushina, Yu. А. Balanova et al. · 2024 · CARDIOVASCULAR THERAPY AND PREVENTION
88. A foundation model for continuous glucose monitoring data
    Guy Lutsker, Gal Sapir, Smadar Shilo, Jordi Merino, Anastasia Godneva, Jerry Richard Greenfield, Dorit Samocha‐Bonet, Raja Dhir, Francisco Gude, Shie Mannor et al. · 2026 · Nature
89. Excess risk of hospitalisation for heart failure among people with type 2 diabetes
    Annika Rosengren, Jon Edqvist, Araz Rawshani, Naveed A. Sattar, Stefan Franzén, Martin Adiels, Ann‐Marie Svensson, Marcus Lind, Soffia Guðbjörnsdóttir · 2018 · Diabetologia
90. Heart failure is a common complication after acute myocardial infarction in patients with diabetes: A nationwide study in the SWEDEHEART registry
    Viveca Ritsinger, Thomas Nyström, Nawsad Saleh, Bo Lagerqvist, Anna Norhammar · 2020 · European Journal of Preventive Cardiology
91. Diabetes Mellitus Is a Chronic Disease that Can Benefit from Therapy with Induced Pluripotent Stem Cells
    Felipe Arroyave, Diana Montaño, Fernando Lizcano · 2020 · International Journal of Molecular Sciences
92. Emerging Diabetes Technologies: Continuous Glucose Monitors/Artificial Pancreases
    ABDULHALIM M. ALMURASHI, Erika Rodriguez, Satish K. Garg · 2023 · Journal of the Indian Institute of Science
93. Efficacy and safety of liraglutide in type 1 diabetes by baseline characteristics in the ADJUNCT ONE and ADJUNCT TWO randomized controlled trials
    Thomas Fremming Dejgaard, Bernt Johan von Scholten, Erik Christiansen, Frederik Flindt Kreiner, Lars Bardtrum, Matthias von Herrath, Chantal Mathieu, Sten Madsbad, ADJUNCT ONE and ADJUNCT TWO Investigators · 2021 · Diabetes Obesity and Metabolism
94. Aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: A new perspective
    Bianca Rocca, Carlo Patrono · 2020 · Diabetes Research and Clinical Practice
95. The future of new drugs for diabetes management
    Clifford J. Bailey, Caroline Day · 2019 · Diabetes Research and Clinical Practice
96. Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: role of the novel biomarker Cyr 61
    Patric Winzap, Allan J. Davies, Roland Klingenberg, Slayman Obeid, Marco Roffi, François Mach, Lorenz Räber, Stephan Windecker, Christian Templin, Fabian Nietlispach et al. · 2019 · Cardiovascular Diabetology
97. Carotid‐Femoral Pulse Wave Velocity as a Risk Marker for Development of Complications in Type 1 Diabetes Mellitus
    Ninna Hahn Tougaard, Simone Theilade, Signe Abitz Winther, Nete Tofte, Tarunveer S. Ahluwalia, Tine W. Hansen, Peter R Rossing, Marie Frimodt‐Møller · 2020 · Journal of the American Heart Association
98. The association between a novel inflammatory biomarker, systemic inflammatory response index and the risk of diabetic cardiovascular complications
    Kaibin Lin, Yang Lan, Wang Ai, Yan Yan, Junbo Ge · 2023 · Nutrition Metabolism and Cardiovascular Diseases
99. Metformin and cardiorenal outcomes in diabetes: A reappraisal
    John R. Petrie, Peter R Rossing, Ian W Campbell · 2020 · Diabetes Obesity and Metabolism
100. Excess Cardiovascular Risk in Type 1 Diabetes Mellitus
     John R. Petrie, Naveed A. Sattar · 2019 · Circulation